Sanofi-Aventis sues Apotex over docetaxol US ANDA
This article was originally published in Scrip
Executive Summary
Sanofi-Aventishas filed suit against Apotexin the US District Court for the District of Delaware, alleging patent infringement related to a proposed generic version of Taxotere (docetaxel injection), thus triggering a 30-month stay of approval while the legal challenge is fought.